Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RAPP Rapport Therapeutics, Inc.

已收盘 11-22 16:00:00 EST

23.09

+0.57

+2.53%

盘后23.09

+0.000.00%

16:02 EST

最高23.36	最低22.60	成交量6.43万
今开22.85	昨收22.52	日振幅3.35%
总市值8.45亿	流通市值2.12亿	总股本3,658万
成交额147.77万	换手率0.70%	流通股本920.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":23.09,"timestamp":1732309200000,"preClose":22.52,"halted":0,"volume":64257,"hourTrading":{"tag":"盘后","latestPrice":23.09,"preClose":23.09,"latestTime":"16:02 EST","volume":497,"amount":11475.73,"timestamp":1732309330522},"delay":0,"floatShares":9200000,"shares":36576457,"eps":-5.809674,"marketStatus":"已收盘","marketStatusCode":5,"change":0.57,"latestTime":"11-22 16:00:00 EST","open":22.85,"high":23.355,"low":22.6,"amount":1477669.200909,"amplitude":0.033526,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.809674,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1717732800000,"adjPreClose":22.52,"postHourTrading":{"tag":"盘后","latestPrice":23.09,"preClose":23.09,"latestTime":"16:02 EST","volume":497,"amount":11475.73,"timestamp":1732309330522},"volumeRatio":0.600657,"impliedVol":0.6763,"impliedVolPercentile":0.5},"requestUrl":"/m/hq/s/RAPP","defaultTab":"news","newsList":[{"id":"2485641736","title":"Rapport Therapeutics, Inc.盘中异动 大幅拉升5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485641736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485641736?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:03","pubTimestamp":1732208588,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时03分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨5.64%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Briacell Therapeutics Corp.、Cidara Therapeutics, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为914.35%、497.20%、364.61%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010309971a7ee0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010309971a7ee0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2484971729","title":"Rapport Therapeutics, Inc.盘中异动 急速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484971729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484971729?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:50","pubTimestamp":1732042217,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时50分，Rapport Therapeutics, Inc.股票出现异动，股价快速上涨5.34%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。其相关个股中，Syros Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为1068.84%、836.88%、146.46%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dogwood Therapeutics, Inc.，振幅分别为91.10%、81.67%、68.54%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120025017971a7805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120025017971a7805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2484606905","title":"Rapport Therapeutics, Inc.盘中异动 急速拉升5.16%报22.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484606905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484606905?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:19","pubTimestamp":1731950390,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时19分，Rapport Therapeutics, Inc.股票出现异动，股价快速拉升5.16%。截至发稿，该股报22.03美元/股，成交量3.5422万股，换手率0.10%，振幅4.75%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119011950a24373db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119011950a24373db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","RAPP","LENZ"],"gpt_icon":0},{"id":"2483377633","title":"Rapport Therapeutics, Inc.盘中异动 早盘股价大跌6.48%报20.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377633?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:49","pubTimestamp":1731682197,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时49分，Rapport Therapeutics, Inc.股票出现波动，股价快速下跌6.48%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.25%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224957971a6db4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224957971a6db4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","RAPP"],"gpt_icon":0},{"id":"2483855339","title":"Rapport Therapeutics, Inc.盘中异动 下午盘大幅下跌5.11%报23.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483855339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483855339?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:35","pubTimestamp":1731522927,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时35分，Rapport Therapeutics, Inc.股票出现异动，股价快速下跌5.11%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114023527abbe591e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114023527abbe591e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4139","BK4007"],"gpt_icon":0},{"id":"2481633133","title":"Rapport Therapeutics, Inc.盘中异动 快速下跌5.17%报22.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481633133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481633133?lang=zh_cn&edition=full","pubTime":"2024-11-06 01:20","pubTimestamp":1730827238,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日01时20分，Rapport Therapeutics, Inc.股票出现波动，股价快速下跌5.17%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106012039971a47bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106012039971a47bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2480058953","title":"Rapport Therapeutics, Inc.盘中异动 快速下跌5.44%报25.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058953?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:57","pubTimestamp":1730390275,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时57分，Rapport Therapeutics, Inc.股票出现异动，股价大幅跳水5.44%。截至发稿，该股报25.38美元/股，成交量1.6869万股，换手率0.05%，振幅5.89%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.38%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031235755ab8c4094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031235755ab8c4094&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2478873014","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨5.12%报25.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478873014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478873014?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:37","pubTimestamp":1730126243,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时37分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028223723971a2aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028223723971a2aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2476213099","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476213099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476213099?lang=zh_cn&edition=full","pubTime":"2024-10-19 03:33","pubTimestamp":1729279992,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日03时33分，Rapport Therapeutics, Inc.股票出现异动，股价大幅下挫5.78%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019033312971a12d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019033312971a12d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","RAPP"],"gpt_icon":0},{"id":"2475266919","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475266919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475266919?lang=zh_cn&edition=full","pubTime":"2024-10-16 03:16","pubTimestamp":1729019780,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日03时16分，Rapport Therapeutics, Inc.股票出现波动，股价大幅上涨5.00%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016031620971a0734&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016031620971a0734&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RAPP","BK4007"],"gpt_icon":0},{"id":"2475360856","title":"Rapport Therapeutics, Inc.盘中异动 大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475360856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475360856?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:55","pubTimestamp":1728914113,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时55分，Rapport Therapeutics, Inc.股票出现异动，股价急速拉升5.08%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014215513a1e08de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014215513a1e08de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2474771672","title":"Rapport Therapeutics, Inc.盘中异动 快速拉升5.18%报20.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474771672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474771672?lang=zh_cn&edition=full","pubTime":"2024-10-11 03:55","pubTimestamp":1728590108,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日03时55分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨5.18%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110355089719f93d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110355089719f93d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2474382407","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.13%报19.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474382407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474382407?lang=zh_cn&edition=full","pubTime":"2024-10-09 02:55","pubTimestamp":1728413709,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日02时55分，Rapport Therapeutics, Inc.股票出现异动，股价急速下挫5.13%。截至发稿，该股报19.96美元/股，成交量4.8644万股，换手率0.13%，振幅6.46%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009025509ab68857f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009025509ab68857f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2472846966","title":"Rapport Therapeutics, Inc.盘中异动 早盘股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472846966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472846966?lang=zh_cn&edition=full","pubTime":"2024-10-04 23:00","pubTimestamp":1728054025,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日23时00分，Rapport Therapeutics, Inc.股票出现波动，股价大幅拉升5.78%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004230026a1de4f16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004230026a1de4f16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2472478573","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.07%报19.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472478573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472478573?lang=zh_cn&edition=full","pubTime":"2024-10-02 23:59","pubTimestamp":1727884750,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日23时59分，Rapport Therapeutics, Inc.股票出现波动，股价急速下挫5.07%。截至发稿，该股报19.28美元/股，成交量7.1082万股，换手率0.19%，振幅6.89%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002235911a1de0670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002235911a1de0670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2470357350","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨5.31%报21.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470357350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470357350?lang=zh_cn&edition=full","pubTime":"2024-09-28 00:04","pubTimestamp":1727453085,"startTime":"0","endTime":"0","summary":"北京时间2024年09月28日00时04分，Rapport Therapeutics, Inc.股票出现波动，股价急速上涨5.31%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240928000445a1dd1656&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240928000445a1dd1656&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2470419952","title":"Rapport Therapeutics, Inc.盘中异动 快速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470419952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470419952?lang=zh_cn&edition=full","pubTime":"2024-09-24 23:48","pubTimestamp":1727192928,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日23时48分，Rapport Therapeutics, Inc.股票出现异动，股价大幅上涨5.26%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Capricor Therapeutics, Inc.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为4007.78%、182.42%、133.62%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.，振幅分别为101.84%、58.52%、45.08%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924234849ab65aaa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924234849ab65aaa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2469110807","title":"Rapport Therapeutics, Inc.盘中异动 早盘急速拉升5.46%报22.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469110807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469110807?lang=zh_cn&edition=full","pubTime":"2024-09-23 22:08","pubTimestamp":1727100488,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日22时08分，Rapport Therapeutics, Inc.股票出现波动，股价大幅上涨5.46%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923220808ab655deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923220808ab655deb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","RAPP"],"gpt_icon":0},{"id":"2468682488","title":"Rapport Therapeutics, Inc.盘中异动 急速下挫5.37%报19.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468682488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468682488?lang=zh_cn&edition=full","pubTime":"2024-09-20 03:48","pubTimestamp":1726775328,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日03时48分，Rapport Therapeutics, Inc.股票出现异动，股价急速下跌5.37%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Exicure, Inc.、Edgewise Therapeutics, Inc.、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为5574.67%、1006.51%、231.79%，振幅较大的相关个股有Exicure, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Galmed Pharmaceuticals Ltd.，振幅分别为110.91%、88.80%、81.88%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092003484898e3828a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092003484898e3828a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2448015096","title":"Rapport Therapeutics(RAPP.US)获TD Cowen首次覆盖，给予买入评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448015096","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448015096?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:11","pubTimestamp":1719929508,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4566","RAPP","BK4207","LENZ","TD","BK4139","BK4585","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rapportrx.com","stockEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":-0.1071},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.3247},{"period":"ytd","weight":0.3247}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rapport Therapeutics, Inc.于2022年2月根据特拉华州法律注册成立，名称为Precision Neuroscience NewCo, Inc.，并于2022年10月更名为Rapport Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，专注于通过发现和开发用于中枢神经系统（“CNS”）疾病患者的转化小分子药物，成为精确神经科学的领导者。","exchange":"NASDAQ","name":"Rapport Therapeutics, Inc.","nameEN":"Rapport Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rapport Therapeutics, Inc.,RAPP,Rapport Therapeutics, Inc.股票,Rapport Therapeutics, Inc.股票老虎,Rapport Therapeutics, Inc.股票老虎国际,Rapport Therapeutics, Inc.行情,Rapport Therapeutics, Inc.股票行情,Rapport Therapeutics, Inc.股价,Rapport Therapeutics, Inc.股市,Rapport Therapeutics, Inc.股票价格,Rapport Therapeutics, Inc.股票交易,Rapport Therapeutics, Inc.股票购买,Rapport Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况